Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities


Cytomyx Holdings is to sell its Cytomyx Limited subsidiary to Serologicals UK for £4m, in order to focus on its US-based biorepository business.

Cytomyx Holdings is to sell Cytocell Technologies, the developer of DNA diagnostic products, to a management-led consortium for an initial £0.6m.

Cytomyx Holdings is to raise £2m in a share placing to help fund the acquisition of Clinomics Biosciences of the US.

Cytomyx has expanded its life sciences business with the £0.1m acquisition from Cytocell of assets for the manufacture of kits utilising DNA probe technology.

Cytomyx is to acquire Cambridge BioScience, the reseller of life science products and services, for an initial £1m.

Cytomyx is planning to raise £3m in a flotation on Aim, in order to expand its drug research business and invest in genomic and proteomics technology.